Peer support to improve diabetes care: an implementation evaluation of the Australasian Peers for Progress Diabetes Program by Aziz, Zahra et al.
 DRO  
Deakin Research Online, 
Deakin University’s Research Repository  Deakin University CRICOS Provider Code: 00113B 
Peer support to improve diabetes care: an implementation evaluation of the 
Australasian Peers for Progress Diabetes Program 
Citation:  
Aziz, Zahra, Riddell, Michaela A., Absetz, Pilvikki, Brand, Margaret, Oldenburg, Brian, on 
behalf of Australasian Peers for Progress Diabetes Project Investigators 2018, Peer support 
to improve diabetes care: an implementation evaluation of the Australasian Peers for 
Progress Diabetes Program, BMC public health, vol. 18, no. 1(262), pp. 1-12. 
DOI: http://www.dx.doi.org/10.1186/s12889-018-5148-8 
 
 
 
 
© 2018, The Authors 
Reproduced by Deakin University under the terms of the Creative Commons Attribution Licence 
 
 
 
 
 
Downloaded from DRO:  
http://hdl.handle.net/10536/DRO/DU:30107095 
RESEARCH ARTICLE Open Access
Peer support to improve diabetes care:
an implementation evaluation of the
Australasian Peers for Progress Diabetes
Program
Zahra Aziz1,2*, Michaela A. Riddell2,3, Pilvikki Absetz4,5, Margaret Brand2, Brian Oldenburg1,2 On behalf of the
Australasian Peers for Progress Diabetes Project Investigators
Abstract
Background: Several studies have now demonstrated the benefits of peer support in promoting diabetes control.
The aim of this study is to evaluate the implementation of a cluster randomised controlled trial of a group-based,
peer support program to improve diabetes self-management and thereby, diabetes control in people with Type 2
Diabetes in Victoria, Australia.
Methods: The intervention program was designed to address four key peer support functions i.e. 1) assistance in
daily management, 2) social and emotional support, 3) regular linkage to clinical care, and 4) ongoing and sustained
support to assist with the lifelong needs of diabetes self-care management. The intervention participants attended
monthly group meetings facilitated by a trained peer leader for 12 months. Data was collected on the intervention’s
reach, participation, implementation fidelity, groups’ effectiveness and participants’ perceived support and satisfaction
with the intervention. The RE-AIM and PIPE frameworks were used to guide this evaluation.
Results: The trial reached a high proportion (79%) of its target population through mailed invitations.
Out of a total of 441 eligible individuals, 273 (61.9%) were willing to participate. The intervention fidelity was high
(92.7%). The proportion of successful participants who demonstrated a reduction in 5 years cardiovascular disease
risk score was 65.1 and 44.8% in the intervention and control arm respectively. Ninety-four percent (94%) of the
intervention participants stated that the program helped them manage their diabetes on a day to day basis. Overall,
attending monthly group meetings provided ‘a lot of support’ to 57% and ‘moderate’ support to 34% of the participants.
Conclusion: Peer support programs are feasible, acceptable and can be used to supplement treatment for patients
motivated to improve behaviours related to diabetes. However, program planners need to focus on the participation
component in designing future programs. The use of two evaluation frameworks allowed a comprehensive evaluation
of the trial from the provider-, participant- and public health perspective. The learnings gained from this evaluation will
guide and improve future implementation by improving program feasibility for adoption and acceptability among
participants, and will ultimately increase the likelihood of program effectiveness for the participants.
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Background
The management and control of Type 2 Diabetes Mellitus
(T2DM) is one of the major challenges confronting health
systems and economies around the world [1]. As one of
the predominant causes of premature death, loss of prod-
uctivity and disability, diabetes was ranked among the top
15 most common causes of global disability-adjusted life
years (DALYs) in 2013 [2]. The expected increase in dia-
betes cases by 55% (642 million people) by 2040, from the
estimated 415 million people currently living with diabetes
worldwide [3] will demand more health care resources
placing further stress on health care systems. Hence, there
is an urgent need to find new effective ways to improve
diabetes self-management and control outcomes for
people with diabetes (PWD) and reduce the public health
impact of T2DM.
Furthermore, due to the complex nature of diabetes
and its self-management, PWD require ongoing emo-
tional, behavioural and social support to adopt and
maintain self-care behaviours that help with the manage-
ment of diabetes, reduce risk of complications and im-
prove the quality of life [4]. However, many PWD find it
difficult to receive such support from their families and
friends [5]. Hence, a major opportunity exists to improve
the management of T2DM through programs aimed at
providing social and emotional support to PWD.
In recent years, peer support programs are seen as a
promising approach in assisting PWD on an ongoing basis
while emphasising sustained behaviour change required
for improved self-management of chronic diseases [6].
Peer support refers to the provision of emotional and in-
formational support, and practical assistance from people
who have experiential knowledge of a condition [7–10],
often in a way that can be mutually beneficial to those
who have the same condition [11].
There is a large body of evidence supporting the posi-
tive impact of peer support on improving self-
management in patients with T2DM such as adopting
healthy behaviours due to increased knowledge and feel-
ing of social connectedness [12–25]. Indeed, currently
available evidence suggests that peer support can not
only improve education and knowledge it can also lead
to better health outcomes [4]. Furthermore, the “peer
support” approach has been acknowledged by the World
Health Organization (WHO) as a feasible, cost-effective
and flexible intervention for improving diabetes care and
outcomes [26]. However, less emphasis has been given
to understanding program implementation.
Recognizing the need to build the evidence base for
peer support, the American Academy of Family
Physicians Foundation, initiated Peers for Progress (PfP)
(http://peersforprogress.org) [27] in 2006. In 2009 PfP
awarded 14 grants (including eight evaluation trials) in 9
countries with the objective to evaluate, demonstrate
and promote peer support for diabetes around the world
[11]. The PfP programme aimed to improve the evidence
base for providing peer support to people with T2DM to
improve self-management of their diabetes. The
provision of community-based peer-led support, directed
towards four key peer support functions, PfP pro-
grammes aimed to promote adoption and maintenance
of lifestyle and behaviour changes. These key functions
were 1) assistance in daily management, 2) providing so-
cial and emotional support, 3) promoting and support-
ing regular linkage to clinical care and community
resources, and 4) provision of ongoing and sustained
support to assist with the lifelong needs of diabetes self-
care management [11]. The Australasian Peers for
Progress - Diabetes Project (PfP-DP) [9], one of the eight
funded evaluation trials, aimed to implement and evalu-
ate a peer-led, group program to provide support to
people with T2DM in Victoria, Australia.
Implementation science is “the scientific study of
methods to promote the uptake of research findings”
[28]. In addition to evaluating interventions’ effective-
ness, there is a considerable need for more research on
factors that enhance implementation of programs and
optimise outcomes in a real-world setting. Without
understanding whether a program was implemented as
planned, there remains an uncertainty for program plan-
ners on how best to plan, design and implement the
various components to achieve desired outcomes in fu-
ture programs [29–31]. Research on the feasibility of ef-
fective peer support programs in diabetes is sparse [14,
17, 18] and there is still much to learn about how best
to implement effective peer support programs.
The primary outcome of the PfP-DP was the predicted
5 year cardiovascular disease risk using the United
Kingdom Prospective Diabetes Study (UKPDS) Risk
Equation at 12 months. Secondary outcomes included
clinical measures, quality of life, measures of support,
psychosocial functioning and lifestyle measures. This
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implementation evaluation paper complements our earl-
ier publication on the clinical and behavioural outcomes
of the PfP-DP that demonstrated a small reduction in
5 year UKPDS risk in both the usual care and the inter-
vention arms and the mean values for biochemical and
anthropometric outcomes were close to target at
12-months [32].
Although published research supports the benefits of
peer support in controlling diabetes, less attention has
been paid to the translation of such research to everyday
practice. There is a need for more research on factors
that enhance implementation of programs and optimise
outcomes for patients. In this paper we evaluate the im-
plementation including the program’s reach, penetration
and participation; the intervention’s fidelity; group effect-
iveness; perceived support by the participants, partici-
pants’ satisfaction, and willingness to continue to use the
strategies learnt through this intervention; and barriers
to participation in the program. In conducting this im-
plementation evaluation, we have used Glasgow’s
RE-AIM (Reach, Effectiveness, Adoption, Implementation,
and Maintenance) framework [33], and Pronk’s PIPE
(Penetration, Implementation, Participation, and Effective-
ness) framework [34]. The details on the utilisation of
these frameworks are included in the Methods section.
The learnings gained from this evaluation will guide
and improve future implementation of peer support pro-
grams by improving program feasibility and acceptabil-
ity, and, thereby, increase the likelihood of positive and
beneficial effects for the participants.
Methods
Study design, setting and recruitment
The detailed study protocol is published elsewhere [9].
Briefly, we conducted a cluster randomised controlled
trial of a peer-led group-based support program for
people with T2DM. Victorian residents aged between 25
and 75 years with T2DM enrolled on the National
Diabetes Services Scheme (NDSS) database for more
than 12 months, were invited by mail to seek further in-
formation from the researchers about the PfP-DP.
Administered by Diabetes Australia, NDSS is an initia-
tive of the Australian Government for providing
diabetes-related information and support services to
people living with diabetes.
A total of 24 support groups consisting of 273 partici-
pants (10–11 group members and 1–2 peer leaders with
diabetes per group) from 24 study locations (Local
Government Authorities (LGAs)) within the state of
Victoria, in Australia, were selected. The inclusion
criteria for selecting LGAs was having a population of >
10,000 and NDSS pharmacy and /or community health/
diabetes health care facility with links to Diabetes
Australia-VIC. The 24 support groups were randomly
allocated to equal numbers of intervention (12) and
usual care (12) groups in each health region. Information
on recruitment and allocation has been provided else-
where [9]. All participants provided anthropometric,
clinical (blood testing, including HbA1c, Cholesterol and
LDL:HDL ratio) and survey data at baseline (prior to
random allocation), and at 6 and 12 months follow-up.
All participants received diabetes self-management edu-
cation prior to allocation. The individual-level primary
outcome was the cardiovascular disease (CVD) risk
using the UKPDS risk equation [32, 35].
Blood glucose levels (HbA1C) were formally checked at
baseline, 6 months and 12 months. HbA1c was chosen be-
cause it reflects glucose control over the prior 3 month
period and is a better measure of long term glucose con-
trol. We compared HbA1c at baseline to that measured at
12 months, since this allowed us to compare those partici-
pants who had completed the program. Results of HbA1c,
Cholesterol and LDL/HDL ratio were made available to all
participants in each study arm at baseline, 6 months and
12 months, along with optimal targets for these measures.
These results were also discussed during the group meet-
ings and strategies to improve clinical measures were
usually the focus of goal setting activities.
Blood glucose monitoring was key information
provided in the participant’s handbook (p58–61) and par-
ticipants were encouraged to implement self-monitoring
especially if they were taking injectable medication.
This study received ethics approval from the Monash
University Human Research Ethics Committee [9].
Intervention program
The PfP-DP intervention was based on the four key peer
support functions: 1) assistance in daily health manage-
ment; 2) social and emotional support; 3) promotion
and support of regular linkage to clinical care and com-
munity resources; and 4) provision of ongoing support
to assist with diabetes self-management [11]. The proto-
col and main outcomes of the intervention program
have been published previously [9, 32]. In brief, the
intervention delivered ongoing support to intervention
participants facilitated by a trained peer leader for
12 months. Support was implemented, through monthly
group meetings, opportunities for shared activities out-
side of the group meetings, educational resources
including diabetes education booklets and DVDs, each
aimed at assisting group members to improve daily self-
management of their diabetes. The peer group format
allowed for ongoing social and emotional support to be
provided by both peer leaders and group members.
During the meetings, group members shared their expe-
riences of living with and self-managing their diabetes
and received ongoing support and guidance from peer
leaders and other group members in setting and
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achieving manageable goals aimed at improving diabetes
control. Group members were also encouraged and sup-
ported to improve and consolidate their relationship
with their clinical care provider.
The program provided training and ongoing support
to peer leaders in facilitating the group meetings
through a 2 ½ day training program at the beginning of
the intervention. A peer leader manual, which contained
training material and other resources, was distributed to
all leaders during training. The research team conducted
weekly teleconferences with peer leaders to provide
emotional, informational and appraisal support for peer
leaders throughout the intervention period. The peer
leaders were encouraged to attend at least one telecon-
ference every month. The research team was available to
provide additional support via teleconference and emails
throughout the program.
Peer leaders and participants had access to a number of
educational resources including a hard copy of a bi-
monthly newsletter ‘Support Share Learn Live’ that was
sent to all intervention participants during the interven-
tion period. Other resources included access to a
password-protected website containing further informa-
tion, resources and education websites; a diabetes educa-
tion manual; a PfP-DP specific Diabetes Self-Management
Education (DSME) DVD; healthy eating book; pedome-
ters; and other informational resources. A participant
workbook was also delivered to all participants.
Evaluation design
Provider- and participant-level implementation out-
comes were evaluated using the RE-AIM [33] and PIPE
[34] frameworks. The RE-AIM framework [33] includes
five dimensions i.e. Reach (R), Effectiveness (E), Adop-
tion (A), Implementation (I), Maintenance (M). The
product of the five components determines the potential
public health impact of an intervention [36]. The PIPE
Impact Metric has four evaluation components i.e. Pene-
tration (P), Implementation (I), Participation (P), Effect-
iveness (E) [34]. Similar to RE-AIM framework, each of
the PIPE Impact Metric elements can be expressed as a
coefficient, and the product of all elements represents
the overall public health impact of an intervention. Both
RE-AIM and PIPE frameworks employ provider-level as
well as participant-level measures. In the PIPE frame-
work these user levels are separate (Penetration and
Implementation for provider and Participation and
Effectiveness for participant). In the RE-AIM framework,
several dimensions (i.e., Reach, Adoption, Maintenance)
include both user levels, which makes it difficult to iden-
tify exactly which program element would need to be
addressed to improve the program. Furthermore, several
reviews have shown that the information on the five
RE-AIM dimensions are largely underreported,
particularly the ‘adoption’ and ‘maintenance’ dimensions
[37–43], and that especially the dimensions of reach and
adoption can be challenging to report with a valid denom-
inator [44]. For both frameworks, the multiplicative model
(R x E x A x I x M / P x I x P x E) of assessing the poten-
tial public health impact of a given intervention implies
that if a program has a zero value on any dimension, that
its overall public health impact will be zero [45].
Table 1 shows the definition of each of the evaluation
components of RE-AIM and PIPE frameworks in the
context of PfP-DP. Figure 1 describes how PfP-DP inter-
vention’s program delivery inputs are evaluated as pro-
vider- and participant-level outcomes.
At the end of 12-months, all intervention participants
were asked to complete a questionnaire designed to assess
the implementation of PfP-DP in line with the four key
peer support functions. The evaluation assessed partici-
pants’ interest and satisfaction with the intervention; group
effectiveness; participants’ perceived support provided by
peer leaders and group members; willingness to continue
use of the strategies learnt through this intervention; and
enablers of and barriers to adoption of the program.
Results
This section follows the logic model for PfP-DP evalu-
ation components as presented in Fig. 1. The results are
Table 1 Definition of RE-AIM and PIPE Components in the context
of PfP-DP
RE-AIM [33] PIPE [34]
Reach (R) Penetration (P)
Proportion of eligible individuals
who were willing to participate
in PfP-DP.
Proportion of the target population
that is reached with invitations to
engage in PfP-DP.
Effectiveness (E) Implementation (I)
The impact of PfP-DP on
primary outcomes.
Fidelity with the intervention protocol.
Participation by the potential program
users in the delivery of intervention.
Adoption (A) Participation (P)
Proportion of settings and
individuals who were willing
to initiate PfP-DP.
Proportion of invited individuals
who enrolled in the program.
Implementation (I) Effectiveness (E)
Fidelity with the
intervention’s protocol.
Proportion of successful participants
based on the primary outcome.
Maintenance (M)
Provider – the extent to which
PfP-DP became part of routine
organisational practice.
Individual - Long-term effects
of PfP-DP on outcomes at
12 months.
Public Health Impact:
R x E x A x I x M
Program Net Impact: P x I x P x E
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presented for the provider- and participant-level
measures using the evaluation components from the two
frameworks.
Provider-level measures
Penetration
The total number of NDSS registrants at the time of re-
cruitment for selected LGAs was 102,492 including all
types of diabetes, of which 9580 were deemed eligible,
by the database custodians (i.e. agree to be contacted for
research purposes), for invitations based on the above
inclusion criteria. Letters of invitation were mailed to
7576 prospective participants with information about
the Australasian PfP-DP and a detachable address form
with reply-paid envelope to contact the project team if
the individual was interested in receiving further infor-
mation about participating in the study.
Penetration Coefficient: Penetration for this trial was
calculated as 7576 / 9580 = 0.790 (79.0%).
Implementation
Intervention components delivered to peer leaders
Two and a half days of group facilitation training was
delivered as planned. Of the 20 identified peer leaders
for the intervention arm, 19 (95%) leaders completed
the compulsory peer leader training aimed at preparing
them for delivery of monthly group sessions to the inter-
vention participants. The research team organised a
weekly one-hour teleconference for 43 out of 47 weeks
(91%). A total of 61% of peer leaders attended at least
one teleconference per month which was the stated re-
quired minimum attendance for these teleconferences.
The “Primus Inter Pares” (English translation: “a first
among equals; the senior or representative member of a
group”) weekly e-newsletter was developed by the re-
search team and sent to peer leaders for 45 out of
47 weeks (96%) during the intervention period. The peer
leaders had access to a range of educational resources
during the intervention period.
The peer leaders were asked to rate how well the train-
ing program prepared them to provide peer support to
their groups, on a scale of 1 to 10, where ten is ‘extremely
well prepared’. Ninety-two percent (92%) of peer leaders
rated 8 or more for the training, and 69% stated that the
training prepared them “extremely well” in delivering peer
support to their groups. All peer leaders indicated that the
training manual and handouts were an ‘invaluable
resource’ or ‘very helpful’ in delivering intervention and
providing peer support to their respective groups.
Eighty-five (85%) leaders stated that the weekly tele-
conferences, weekly e-newsletters, and Peers for
Progress Website provided them ‘moderate’ to ‘a lot of
support’ in providing support to their group members.
All peer leaders stated that they received ‘a lot of sup-
port’ from research staff in reference to the diabetes
information, whereas, 75% stated that the research team
provided a lot of administrative support. Seventy-seven
percent (77%) of the peer leaders stated that they would
Fig. 1 Logic model for PfP-DP evaluation design
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like to continue to lead their peer support group after
the completion of the formal intervention.
Intervention components delivered to group members
by peer leaders in assistance with research team
Monthly group meetings were organised as scheduled
for 11 of the planned 12 groups (92%) at a location con-
venient to the group members. For one group location
allocated to receive the intervention, insufficient group
members were recruited. This group was then combined
with another location. These 11 groups met at least 12
times over the 12-month period. Nine out of 11 groups
recorded an average attendance of 59% over the
12-month intervention. Two groups did not provide
regular data on attendance.
Implementation Coefficient: We calculated the imple-
mentation coefficient by assessing the three major com-
ponents delivered during the intervention i.e. Peer
leaders training (95%), Weekly teleconference (91%),
and Monthly group meetings (92%). Hence, the average
proportion of the implementation components delivered
during the intervention period according to the pre-
scribed protocol was calculated as 92.7%. Hence, the im-
plementation coefficient is determined to be 0.93 (93%).
Adoption
A total of 24 clusters (towns/cities) within 20 LGAs
from 5 Regional and 3 Metropolitan health regions in
the state of Victoria were recruited for the study. Twelve
clusters were randomised and allocated to each control
and intervention arms, out of which 11 clusters received
the intervention.
Adoption Coefficient: Setting-level adoption was calcu-
lated as 11 / 12 = 0.916 (91.6%).
Participant-level measures
Reach / participation
The detailed consort diagram and participants’ demo-
graphics have been published previously [32]. Briefly,
out of 7576 mail invites, 294 were returned due to incor-
rect address details on the NDSS register. Of the
remaining 7282 mails, expressions of interest were re-
ceived by 501 (6.9%) individuals. Of these, 441 (88.0%)
persons were eligible to enter the study and were sent
recruitment packs including further information about
the program and consent forms. Of these, 151 (34.2%)
declined to participate, while 290 (65.7%) provided in-
formed consent. Of 290, 17 (5.9%) withdrew their con-
sent prior to random allocation of groups. Thus 273
individuals (94.1%) were available to participate in 24
groups. Of 273 individuals willing to participate, 33
volunteered and were deemed suitable for the role of
peer leaders. Out of the remaining 240 participants, 120
(50%) were allocated into 12 groups in each of the
intervention and control arm, governed by a random
number generation process. Eighty-three percent and
82% of participants in the intervention arm completed
6-months and 12-months measurements respectively.
Reach Coefficient: Out of a total of 441 eligible individ-
uals, 273 were willing to participate. Hence, the reach
coefficient is calculated to be 273 / 441 i.e. 0.619
(61.9%).
Participation Coefficient: Out of a total of 7282 indi-
viduals who were sent mail invites to participate in the
trial, 273 (3.7%) were enrolled. Hence, the participation
coefficient is 273 / 7282 i.e. 0.037 (3.7%).
Effectiveness
The results on the effectiveness of the intervention with
respect to the primary and secondary outcomes of the
trial using the 5 year UKPDS risk score at baseline and
12 months have been published separately [32]. Briefly,
the proportion of participants who showed improvement
in the primary outcome i.e. reduction in 5 years UKPDS
risk score was 0.651 (65.1%) in the intervention arm and
0.448 (44.8%) in the usual care group.
Effectiveness Coefficient = 0.651 (65.1%).
The findings of the effectiveness of the intervention
delivery according to four key peer support functions are
presented in Table 2. At the end of 12-months, two-
thirds (N = 81, 67.5%) of the intervention participants
completed the evaluation questionnaire.
According to RE-AIM, participant-level ‘adoption’
refers to reach and participation which is reported
above. Similarly, participant-level ‘maintenance’ refers to
long-term effectiveness, which is already reported under
effectiveness. Hence, we do not report these two compo-
nents separately.
Barriers to participation in program
At the end of 12-months, peer leaders were asked about
the barriers that may have limited group members’ par-
ticipation in group meetings. Five leaders reported
barriers such as health issues and lack of time. Only one
peer leader stated that the timings of the group meetings
were not suitable for some participants. Similarly, group
members were asked whether there were any factors that
may have limited their participation in group meetings.
More than half (56%) of the participants reported no
barriers. Forty-four percent of respondents reported one
or more factors including health issues (37%), lack of
time/work commitments (37%), location/timings (37%),
and issues in family/family commitments (14%).
Willingness to continue Behavioural change
At the end of 12 months, participants were asked
whether they intended to use any strategies learnt in this
program to self-manage their diabetes in the future. The
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majority of participants stated that they intended to con-
tinue to use strategies learnt in this program including
healthy diet (91%), seeking timely clinical care (82%),
regular exercise (77%), blood glucose monitoring (76%),
and utilising social and emotional support (74%).
Public health impact / program net impact
As stated above, for both frameworks, the multiplicative
model (R x E x A x I x M / P x I x P x E) of assessing the
potential public health impact or program net impact of a
given intervention implies that if a program has a zero value
on any dimension, that its overall public health impact will
be zero. Since we do not have coefficients of all five dimen-
sions of RE-AIM, we use coefficients from four elements of
the PIPE framework, to calculate the net program impact as
the product of all four PIPE Impact Metric elements, i.e.
Penetration (0.790) X Implementation (0.927) X Partici-
pation (0.037) X Effectiveness (0.651) = 0.0176 (1.76%).
Despite the very high rate of penetration (79%) and
implementation (92.7%), and moderate effectiveness
(65%), the net program impact (1.76%) of the PfP-DP
intervention remains very low, a likely reflection of the
low participation rate (3.7%).
Discussion
In recent years, an increasing emphasis has been placed
on the translation and implementation of research
findings into real-world settings. This has resulted in an
increase in the reporting of implementation evaluations
in addition to reporting the primary and secondary out-
comes. While the last 10 years has seen a big increase in
the number of publications reporting the outcomes of
peer support programs to improve diabetes outcomes [7,
12, 14–25], few have focussed on the ways in which such
programs are affected by the local context and environ-
ment. Therefore, little is known about the implementa-
tion approaches of peer support programs. This paper
reports the evaluation of the implementation of a peer-
led, group-based program designed to provide support
to people with T2DM in Victoria, Australia.
In undertaking this implementation evaluation, we
have used Glasgow’s RE-AIM [33] framework that has
been extensively used as an evaluation framework to
guide both the design and evaluation of health program
implementation [40]. We also use Pronk’s PIPE [34]
Impact Metric that is also highly relevant to implemen-
tation. In using these two frameworks, we present a for-
mal assessment of the net impact of health improvement
Table 2 Effectiveness of the intervention delivery according to the four key peer support functions at 12 months
Key Functions (KF) Participants’ evaluation
KF 1:
Assistance in daily management
of diabetes
• Ninety-four percent (94%) participants reported that the PfP-DP helped them manage their diabetes on a
day to day basis ‘all the time’ (18%) and ‘to some extent’ (76%). Only 6% group members stated that the
PfP-DP did not help them at all in managing their diabetes.
• More than 90% of the group members stated that they were supported by their peer leaders in setting
specific goals to improve their eating or exercise, in learning skills and behaviours to take care of their
diabetes, and in solving problems that came up in taking care of their diabetes.
KF 2:
Provision of promotion and social
and emotional support
• Seventy-eight (78%) and 72% group members indicated that their peer leaders and other group members
respectively supported them in dealing with stress.
• However, about one-third (28%) felt that they could not call upon their peer leaders or other group
members when they were feeling low or needed help from them.
• Sixty-eight percent (68%) of participants when asked if they had received any ongoing social and emotional
support in relation to their diabetes, besides participating in this program, responded that they had received
additional support, mainly from their GPs and family members.
KF 3:
Assistance in creating linkage
with clinical care services
• Group members reported that the peer leaders reminded them to see their health care providers, very
often (40%) to some of the time (38%), even when they were not sick.
• Group members reported that peer leaders made referrals to community resources to help participants
with clinical care from ‘very often’ (31%) to ‘some of the time’ (39%).
• Seventy-eight percent (78%) of participants stated that their peer leaders asked them about problems
with their medicines or their effects.
• A total of 68% and 59% participants felt that their peer leaders and other group members respectively
have helped them build better communication skills to use during their health care visits.
KF 4:
Provision of ongoing support
to assist with diabetes self-management
• Seventy-five percent (75%) and 63% of participants stated that they were able to contact and reach their
peer leaders and other group members respectively, outside the monthly group meetings.
• Seventy-five percent (75%) of the participants felt that their peer leaders maintained contact with them,
and worked with them over time to help them manage their diabetes.
• Ninety-five percent (95%) of the participants stated that peer leaders and other group members were
able to contact them outside of the monthly group meetings.
• The participants were asked about the extent to which the additional resources provided support. Diabetes
Information Sheets, Healthy Eating Booklet, Diabetes Education and Manual, and Support Share Learn Live
Newsletter provided a lot of support to 59, 55, 48 and 41% of participants respectively.
• Overall, attending monthly group meetings provided ‘a lot of support’ to 57% and ‘moderate’ support to
34% of the participants. Only 8% of the group members felt that monthly group meetings provided only
a little support in managing their diabetes.
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programs conducted in real-world settings, with a clear
distinction between the program providers’ and partici-
pants’ perspectives [46].
While assessing provider-level measures, we have re-
ported trial penetration that reflects the efforts to reach
each individual in the target population. As a
community-based trial, we attempted to utilise common
methods of recruitment which would be amenable to
scale up such as invitation by mail, posters in various lo-
cations including clinics and pharmacies, and on
Diabetes Australia -VIC website. Whilst achieving a very
high rate of penetration (79%), reaching a large propor-
tion of the target audience by mail invitations, the ap-
proach was low-intensity which may have limited
influence in motivating the target population to partici-
pate. as compared to a well-designed social marketing
campaign as observed in some other studies [47, 48].
Furthermore, postal invitation is a low-cost economic
option for reaching target populations, the limitations of
mail invitations are well documented [49]. We have con-
ducted a systematic review of 38 real-world diabetes pre-
vention programs from the last 15 years, using the PIPE
Impact Metric framework and found that ‘high’ penetra-
tion into the target population with invitations to engage
prospective participants in the program do not necessar-
ily result in ‘high’ participation [46].
Interestingly, our calculation of reach (61.9%) and
participation (3.7%) shows an enormous difference be-
tween these two concepts. According to the RE-AIM
framework reach is calculated as the proportion of eli-
gible individuals who were willing to participate (61.9%),
whereas, the PIPE’s calculation of participation applies
to the proportion of the invited individuals who enrolled
in the program (3.7%). Although the later proportion
might seem very low, it should be noted that one of the
aims of our efficacy trial was to assess the feasibility of a
community-based peer-led program in a real-world set-
ting. Our approach was confined to letters to the target
audience, inviting them to enrol in the study after satis-
fying eligibility and screening criteria. The low participa-
tion observed in our study is consistent with some
diabetes prevention studies that have used mail invita-
tions to recruit the potential participants [50, 51].
Furthermore, in our study, recruitment of peer leaders
required their willingness to self-nominate for peer lead-
ership and was tied to invitations to participate. In our
experience, in other international studies, recruitment of
peer leaders in India has been relatively straight forward
[52, 53]. In Finland where we have initiated ongoing peer
support for participants completing the nurse-facilitated
GOAL lifestyle change groups to prevent T2DM [54],
the peer-led support groups are built on the basis of an
already existing platform, and the peer leaders have been
slowly introduced to the role, along with strengthening
of their self-efficacy. Furthermore, a recruitment strategy
was designed in collaboration with the peer leaders and
the nurse facilitators. This included a regular visiting
schedule by the peer leaders to the GOAL groups to
advertise the peer support meetings and invite new par-
ticipants [54]. People living with T2DM may feel unable
or ill-equipped to self-manage, and, to help others re-
quires a higher level of confidence in self-management
capacity. Future programs may benefit from distinct and
detached strategies for participant recruitment and peer
leader recruitment, and potentially higher intensity con-
tact with the peer leaders before the program starts.
Furthermore, several diabetes prevention studies have
shown high participation rates where recruitment was
carried out by referrals from physicians, general practi-
tioners, or nurses from the participating health facilities
[55, 56].. Future program planners should review the de-
sign and marketing strategies of the program.
In layman’s terms, ‘participation’ is considered as the
willingness of participants to commence and adhere to
the program. However, in our evaluation using PIPE
metric, the participation by the potential users in the
delivery of intervention falls under ‘implementation’.
Hence, while calculating the implementation score, in
addition to implementation fidelity, we specifically con-
sidered the participation in three major intervention
delivery components i.e. “peer-leaders training”, “weekly
teleconference”, and “monthly group meetings”. The in-
dividual implementation score varied from 91.5% for a
weekly teleconference to 95% for the peer leader train-
ing. Program implementers succeeded in implementing
the peer leader training, monthly group meetings and
weekly teleconference as planned. The monthly group
meetings provided support to the majority of partici-
pants in managing their diabetes. The participants’
perception of support received by peer leaders and other
group members in reference to the four key peer sup-
port functions was also encouraging. A large majority of
group members felt that they received assistance in the
daily management of diabetes, which is an important
finding. However, these findings should be viewed with
caution as our results on the satisfaction of the program
are based on the responses received by two-thirds of the
participants only. The remaining one-third of the partic-
ipants did not respond to the 12-month evaluation ques-
tionnaire. We also noted that 44% of these respondents
reported factors that may have contributed to their lack
of participation in the program, such as health issues,
lack of time, work commitments, the location of
monthly group meetings, timings of sessions, personal
issues and family commitments. Future program imple-
mentation should endeavour to consider these barriers
in the design and development of second generation
peer support programs.
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Our current calculation of PIPE Impact Metric shows a
small overall impact of 1.76%, which, although low, should
be placed in the context of what may be a ‘theoretically’
realistic impact in the real-world settings. The PfP-DP has
been moderately effective with an individual success rate
of 65% in the intervention arm, but the effectiveness of
the overall program is dramatically diminished due to the
very low participation discussed above. While our recruit-
ment approach via the national register for PWD in
Australia was feasible and cost effective, such an approach
may not be suitable for reaching those individuals with
poor diabetes control and those experiencing other com-
plications, who would likely benefit the most from such a
program. In a hypothetical scenario for a similar program,
keeping all the PIPE coefficients the same as PfP-DP
except imputing a participation rate of 20% instead of
3.7%, as in our program, the overall program impact could
increase to almost 10%, while similar increase in effective-
ness would only give a 2% impact. Hence, the incremental
benefit from increased effectiveness of intervention is
bound to be much smaller than the incremental benefit
from effective recruitment.
The assessment of the overall public health impact of an
intervention could be invaluable in guiding and informing
future translation and dissemination of the results into
policy and practice. However, the measurement of public
health impact of real-world interventions is a complex
issue and is not reported widely. Compernolle and
colleagues [37] conducted a systematic review of 35 inter-
ventions which used the RE-AIM framework to assess the
potential public health impact of evidence-based multi-
level interventions to improve obesity-related behaviours
in adults. The authors reported that only three studies out
of 35 reported on all five dimensions of RE-AIM. Authors
then calculated the average RE-AIM score to assess the
potential public health impact of interventions and
concluded that one of the three interventions had
achieved the highest potential public health impact, des-
pite its low participation rate. This is in contrast to our
calculation of program impact using the PIPE Impact
metric, where the PfP-DP had a very low net impact due
to the low participation rates. However, it should be noted
that Compernolle et al. [37] calculated the public health
impact by taking the average of all RE-AIM components,
whereas, we have calculated the net impact by taking the
product of the four dimension of PIPE (as per the defin-
ition of PIPE Impact Metric) [34] and hence achieved
1.76%. If we had used the same method, the public health
impact of the PfP-DP would have been 60%. Hence, in our
view, Compernolle et al. presents an overestimation of the
overall public health impact.
While the RE-AIM framework has continued to evolve
and has been increasingly used to facilitate the transla-
tion of research findings, there are some limitations in
applying reporting criteria for all five dimensions of
RE-AIM [39]. In our view, the RE-AIM definition of
individual-level maintenance is equivalent to long-term
effectiveness. Traditionally many research trials do not
collect follow-up data at approximately 12 months after
intervention cessation, and this may not be practical in a
research context. Similarly, like other authors [44] we
found the definition of reach and individual-level adop-
tion overlapping and we could not differentiate between
the two. In our view, ‘adoption’ should relate to the will-
ingness to adopt the strategies taught in the intervention
(e.g., goal setting, improving diet, increasing physical
activity, etc.)
In a recent systematic review of diabetes prevention
programs, we analysed 38 studies, choosing the PIPE
Impact Metric for evaluation rather than the RE-AIM.
We determined the PIPE framework to be more appro-
priate, informative and less complex in evaluating the
degree of program impact on its objectives. This frame-
work considers both provider related factors i.e. penetra-
tion and implementation, and participant related factors
i.e. participation, and effectiveness [46]. More examples
of program evaluation using the PIPE metric is needed
so that similar programs could be compared based on
the overall PIPE metric. Mapping the components from
the two models into provider- and participant-level
factors for this evaluation, allowed us to undertake a
comprehensive evaluation of PfP-DP from providers’ as
well as participants’ perspective.
When combined with outcome evaluation, implemen-
tation evaluation can contribute to an evidence base for
wider implementation and scale up of research
programs, potentially achieving population-level impact;
and for facilitating the translation of research trials into
successful public health programs in real-world settings.
This is also true for trials that report only modest effects
as achieved in our study. Our findings show that a
group-based, peer support program to assist people in
improving diabetes control, is feasible and acceptable as
measured by participants. Participant satisfaction, per-
ceived support, usefulness of program training/strategies
and resources, willingness to use strategies learnt in the
program in future as well as the moderate primary out-
come measured by success rate support feasability and
acceptability of our programme. Furthermore, the
participation rate although adequate for research pur-
poses was low in terms of public health impact. If
disseminated, future programs should focus on better
participation strategies such as better communication
strategies, clearly stated benefits of the program, and
outreach strategies of sufficient intensity to ensure max-
imum participation. The design and development stages
of the Australasian PfP-DP did not invite participants
into program planning. Future programs aimed at self-
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management of T2DM may need to more effectively en-
gage with target groups. Without a participatory ap-
proach, we might not be able to overcome issues related
to low participation rates for such programs. Further re-
finements are needed for improving the participation
rates in future programs. More research is needed to
bring structured and effective peer support programs to
PWD to assist them in improving self-management and
reducing subsequent morbidity and mortality.
Conclusion
The Australasian PfP–DP was implemented in accordance
with the four key peer support functions i.e. 1) assistance
in daily health management; 2) social and emotional sup-
port; 3) promotion and support of regular linkage to
clinical care and community resources; and 4) provision
of ongoing support to assist with diabetes self-
management. The use of two evaluation frameworks
allowed a comprehensive evaluation of the PfP-DP from
the provider-, participant- and public health perspective.
Our findings suggest that peer support programs can be
feasible and acceptable and that they have the potential to
create a positive impact on the quality of life of people
with T2DM, which ultimately increases the likelihood of
program effectiveness for the participants. However, pro-
gram planners should enhance focus on the participation
component in designing future programs. More examples
of program evaluation using PIPE metric are needed so
that similar programs could be compared based on the
overall PIPE metric. The results of this evaluation will help
in understanding peer-support programs better and will
elucidate improvements for future replications of such
programs both in Australia and in other similar settings.
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